Post Profile

EpiPen Moms Speak Out For CA Prop 61 And Against Drug Company Price Gouging

News that Mylan must pay $465 million to the US government for overcharging Medicaid for the EpiPen is the poster child for why Californians need Proposition 61. That's why EpiPen moms and kids spoke out this week for the ballot measure, saying it would save lives. They warned Californians against deceptive drug company advertising against Prop 61. Drug companies, who are spending $90 million to stop Proposition 61, will continue to overcharge Californians until we pass Prop 61 to stop their price gouging.
read more


Related Posts

More on Mylan's EpiPen profiteering: It allegedly ripped off Medicaid, too

Business & Finance : Money & Co

Very quietly, on the Friday before a long Federal holiday weekend, Mylan last week paid $465 million to stifle government allegations that it had systematically overcharged Medicaid for its notorious EpiPen medical device. This sum ...

Mylan to pay $465-million settlement over Medicaid EpiPen rebates

Business & Finance : LA Times: Business

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection. The federal government says EpiPen is a branded drug, which means Mylan should have been paying a far higher...

EpiPen Maker Mylan Will Pay $465 Million to Settle Medicaid Overcharging Case

Business & Finance : DealBook

Mylan said the settlement, after the government had said it improperly classified EpiPen as a generic drug, did not imply any admission of wrongdoing.

The maker of EpiPen has agreed to pay the government $465 million after allegedly overcharging for the medicine

Business & Finance : Business Insider: Money Game

Mylan, the marker of the EpiPen, has agreed to pay the federal government a $465 million settlement after it allegedly overcharged government healthcare agencies for the medicine, according to a release from the firm. Mylan had unde...

Mylan to pay $465 million over Medicaid pricing of EpiPen

Business & Finance : Mashable: Business

Mylan will pay the Department of Justice $465 million in a settlement over its pricing and classification of the EpiPen through Medicaid, the pharmaceutical company announced Friday.  Mylan, which came under fire this summer for sys...


Copyright © 2016 Regator, LLC